Rain Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

NEXT STORY
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
PREV STORY
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program

Single dose of vaccine showed 67% survival rate and 100% survival rate after two ...

author_avatar
NASDAQ Market News

Inspyr Therapeutics Announces Research Collaboration with University of Virginia School of Medicine

WESTLAKE VILLAGE, Calif., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Inspyr Therapeutics (OTCQB:NSPX), a clinical-stage ...

author_avatar
NASDAQ Market News

3D Signatures Reports First Quarter Financial Results for Fiscal 2018

TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the ...

author_avatar
NASDAQ Market News